Fig. 2
From: Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
![Fig. 2](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12933-021-01392-6/MediaObjects/12933_2021_1392_Fig2_HTML.png)
Empagliflozin did not alter baseline ECGs. A Exemplar baseline surface ECGs from rats with or without empagliflozin. CON, control; Em, empagliflozin. B Quantification of ECG parameters; n = 13–15. All group comparisons, P > 0.05. CON, control; Em, empagliflozin. RR, RR interval; HR, heart rate; PR, PR interval; QRS, QRS interval; QT, QT interval; QTc: QT interval calculated based on Mitchell’s formula (see “Materials and methods”)